FDA Redefining AI Breakthrough Standards: Voice-Based Heart Failure Detection, Post-Surgical Chatbots, and the New Regulatory Framework - April 4, 2026

FDA Redefining AI Breakthrough Standards: Voice-Based Heart Failure Detection, Post-Surgical Chatbots, and the New Regulatory Framework - April 4, 2026 The FDA is fundamentally rethinking what qualifies as an AI breakthrough medical device, raising the bar from incremental improvements to systems that do what no doctor can. We explore Noah Labs' Vox voice-based heart failure detection, RecovryAI's post-surgical chatbot, and Commissioner Makary's new regulatory framework. Hosted by Chris and...